---
title: Buy Ticlopidine 250mg Pills Online
description: Ticlopidine is an antiplatelet medication for stroke prevention and blood clot reduction. Order 250mg pills from our trusted online pharmacy.
type: product
language: en 
url: https://liabilis.com/order-ticlopidine-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 151.99
price_max: 596.59
currency: USD
offers:
  - name: 250mg x 30 pills
    price: 151.99
  - name: 250mg x 60 pills
    price: 265.04
  - name: 250mg x 90 pills
    price: 379.99
  - name: 250mg x 120 pills
    price: 436.99
  - name: 250mg x 180 pills
    price: 596.59
---

# Buy Ticlopidine 250mg Pills Online

Ticlopidine is an antiplatelet medication that helps prevent blood clots from forming, particularly in patients at risk of stroke or with certain heart conditions. It works by inhibiting platelet aggregation, reducing the likelihood of dangerous clot formation. This medication is designed for adults requiring blood thinning therapy. Our online pharmacy offers reliable access to generic Ticlopidine in 250mg pill form for cardiovascular protection.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **250mg** | 30 pills | **$151.99** | $5.06 | In Stock |
| **250mg** | 60 pills | **$265.04** | $4.42 | In Stock |
| **250mg** | 90 pills | **$379.99** | $4.22 | In Stock |
| **250mg** | 120 pills | **$436.99** | $3.64 | In Stock |
| **250mg** | 180 pills | **$596.59** | $3.32 | In Stock |


[Buy Now](https://liabilis.com/order-ticlopidine-online-en.html)

## Introduction 

Ticlopidine is an oral antiplatelet medication used to reduce the risk of blood clots in patients with a history of atherosclerotic disease. The active ingredient is ticlopidine, supplied as a 250 mg tablet. It belongs to the thienopyridine class of platelet-aggregation inhibitors. Ticlopidine’s primary approved uses are secondary prevention of ischemic stroke or transient ischemic attack (TIA) and management of peripheral arterial disease. Because of a higher incidence of serious hematologic adverse reactions compared with newer agents, ticlopidine is now prescribed less frequently, but it remains a therapeutic option for patients who cannot tolerate alternatives.

## Quick Reference Facts 

```
**Active Ingredient**
: Ticlopidine 

**Form**
: pill 250 mg 

**Primary Uses**
: • Secondary prevention of ischemic stroke/TIA 
 • Peripheral arterial disease (PAD) management 
``` 

## What is Ticlopidine? 

Ticlopidine is a synthetic thienopyridine that inhibits platelet aggregation by irreversibly binding to the P2Y12 ADP receptor on platelets. It was originally developed in the 197s and marketed under the brand name Ticlid. The product is now available as a generic medication, meaning ticlopidine is the generic version of medications containing the active compound ticlopidine. Generic ticlopidine offers the same pharmacologic effect as the former branded formulation while providing cost savings for patients. The drug is manufactured by several licensed pharmaceutical companies that meet international quality standards.

## How Ticlopidine Works 

Platelets require activation by adenosine diphosphate (ADP) to form a clot. Ticlopidine’s active metabolite binds covalently to the P2Y12 receptor, preventing ADP from transmitting its signal. This blockage reduces the conversion of glycoprotein IIb/IIIa receptors to an active state, thereby inhibiting fibrinogen binding and platelet cross-linking. The effect is irreversible; newly formed platelets are required to restore normal aggregation, which typically occurs over 7-10 days. Ticlopidine is absorbed orally, reaches peak plasma concentrations within 1-2 hours, and is metabolized in the liver by cytochrome P450 enzymes (primarily CYP2C19 and CYP2B6) to an active metabolite. The drug’s half-life is approximately 12 hours, supporting a twice-daily dosing regimen.

## Conditions Treated with Ticlopidine 

- **Secondary prevention of ischemic stroke/TIA** 
 Patients who have experienced a non-cardioembolic stroke or TIA are at high risk for recurrent events. Ticlopidine reduces platelet-mediated thrombosis in cerebral arteries, lowering the likelihood of another ischemic episode.

- **Peripheral arterial disease (PAD)** 
 In PAD, atherosclerotic plaques narrow limb arteries, and platelet activation contributes to disease progression. Ticlopidine improves limb perfusion by limiting clot formation, thereby decreasing ischemic pain and the need for surgical intervention.

*(Only the above indications are approved by regulatory agencies for ticlopidine.)*

## Is Ticlopidine the Right Medication for You? 

Ticlopidine is appropriate for adults who require antiplatelet therapy and for whom newer agents such as clopidogrel are contraindicated, poorly tolerated, or unavailable. Ideal candidates include patients with a recent non-cardioembolic stroke/TIA or documented PAD who have normal baseline blood counts and liver function. Ticlopidine should be avoided in individuals with a history of neutropenia, thrombocytopenic purpura, severe hepatic impairment, or known hypersensitivity to thienopyridines. Because the drug can cause delayed hematologic toxicity, regular monitoring of complete blood counts (CBC) is essential during the first three months of therapy. Patients taking concomitant medications that strongly inhibit CYP2C19 (e.g., fluconazole, omeprazole) may experience altered ticlopidine metabolism and should be evaluated by a clinician.

## Buying Ticlopidine from [our online pharmacy](https://liabilis.com/order-ticlopidine-online-en.html) 

### Why Choose Our Service? 
Accessing ticlopidine can be challenging due to limited stock in some regions and higher prices for brand-name formulations. [our online pharmacy](https://liabilis.com/order-ticlopidine-online-en.html) provides a straightforward way to obtain the generic 250 mg tablets at a cost comparable to wholesale pricing, helping you stay adherent without financial strain.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of ticlopidine is sourced from manufacturers that comply with Good Manufacturing Practices (GMP) and is verified by third-party quality auditors before shipment.

### Pricing & Access 
The generic version of ticlopidine is typically 40-60 % less expensive than the former brand Ticlid, making long-term therapy more affordable. Our platform also offers discreet packaging and multiple delivery options, so you can receive the medication without revealing its nature to others.

### Discreet Delivery 
Orders are packaged in unmarked, tamper-evident envelopes and dispatched with express delivery typically within 7 days or standard airmail in approximately 3 weeks. Tracking information is provided so you can monitor progress securely.

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing** 
 The usual adult regimen is 250 mg taken orally twice daily (morning and evening) with or without food. Dosage adjustments are not routinely required for age or weight but may be necessary in hepatic impairment under physician guidance. 

- **Missed dose** 
 If you realize a dose was missed within 4 hours, take it as soon as you remember. If it is later than 4 hours, skip the missed dose and resume the regular schedule. Do not double-dose to compensate. 

- **Overdose** 
 In the event of an accidental overdose, seek emergency medical care immediately. Overdose may intensify antiplatelet effects, increasing bleeding risk. Supportive care, including observation of vital signs and laboratory monitoring, is the primary management strategy. 

- **Practical precautions** 
 • Avoid excessive alcohol, which can heighten liver toxicity. 
 • Do not operate heavy machinery or drive if you experience dizziness or bleeding. 
 • Store tablets at 20-25 °C (68-77 °F) in a dry place, away from direct sunlight.

## Safety Information 

### ⚠️ Who Should Not Take Ticlopidine 

- Patients with a documented history of neutropenia, agranulocytosis, or thrombotic thrombocytopenic purpura (TTP). 
- Individuals with active severe hepatic disease (Child-Pugh class C). 
- Known hypersensitivity to ticlopidine or any component of the tablet formulation. 

### Common Side Effects 

- **Gastrointestinal:** mild nausea, dyspepsia, or abdominal discomfort (approximately 10 % of users). 
- **Hematologic:** reversible mild leukopenia or thrombocytopenia (1-3 %); routine CBC monitoring mitigates risk. 
- **Dermatologic:** mild rash or pruritus, usually transient. 

Management typically involves symptom-directed care and continued monitoring; most events resolve without discontinuation.

### Serious Side Effects (Seek Immediate Medical Help) 

- **Severe neutropenia or agranulocytosis** - characterized by fever, sore throat, or unusual infections. 
- **Thrombotic thrombocytopenicpura (TTP)** - presents with sudden bruising, petechiae, neurologic changes, or hemolytic anemia. 
- **Severe hepatic injury** - indicated by jaundice, dark urine, or markedly elevated liver enzymes. 

If any of these occur, discontinue ticlopidine promptly and obtain emergency medical evaluation.

### Drug & Food Interactions 

- **CYP2C19 inhibitors (e.g., fluconazole, omeprazole):** may increase plasma levels of ticlopidine’s active metabolite, enhancing bleeding risk. 
- **Warfarin or other anticoagulants:** additive antithrombotic effect raises hemorrhage probability; INR and clinical status should be closely monitored. 
- **Non-steroidal anti-inflammatory drugs (NSAIDs):** concurrent use can exacerbate gastrointestinal bleeding. 
- **Alcohol:** heavy consumption may worsen hepatic toxicity; limit to moderate intake. 

Patients should provide a complete medication list to their prescriber before initiating ticlopidine.

## Off-Label and Investigational Uses of Ticlopidine 

- **Coronary artery disease (CAD) after percutaneous coronary intervention (PCI):** Some early trials explored ticlopidine as an alternative to clopidogrel for preventing stent thrombosis, but due to safety concerns it is not recommended in current practice. 
- **Acute coronary syndrome (ACS):** Limited observational data suggest possible benefit, yet guidelines favor clopidogrel or newer P2Y12 inhibitors. 
- **Stroke prevention in patients with atrial fibrillation who cannot tolerate anticoagulation:** Rarely used off-label; evidence is insufficient, and anticoagulants remain first-line. 

All off-label applications should be undertaken only under direct supervision of a qualified healthcare professional, with careful risk-benefit assessment.

## Storage & Handling 

- Store ticlopidine tablets at 20-25 °C (68-77 °F). 
- Protect from excess moisture and direct sunlight. 
- Keep out of reach of children and pets. 
- Do not use tablets beyond the expiration date printed on the container. 
- Dispose of unused medication according to local pharmacy-take-back programs or hazardous waste guidelines.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with ticlopidine?** 
 Yes, but carry the medication in its original labeled container, along with a copy of the prescription or a physician’s note, to satisfy customs regulations in most countries. 

- **Does ticlopidine interact with vitamin C supplements?** 
 No clinically significant interaction has been documented between ticlopidine and vitamin C. 

- **Should I take ticlopidine at the same time each day?** 
 Maintaining a consistent dosing schedule (morning and evening) helps sustain steady platelet inhibition and simplifies adherence. 

**Product & Formulation Details** 

- **What do ticlopidine tablets look like?** 
 Generic 250 mg tablets are typically round, white to off-white, and may be film-coated. Appearance can vary slightly between manufacturers. 

- **Are any inactive ingredients likely to cause allergies?** 
 Common excipients include lactose, microcrystalline cellulose, and magnesium stearate. Patients with known hypersensitivity to these substances should discuss alternatives with their provider. 

**Regulatory & Safety Nuances** 

- **Will ticlopidine show up on a standard drug test?** 
 Routine workplace drug screens do not detect ticlopidine, as it is not a controlled substance. 

- **Is ticlopidine safe for elderly patients?** 
 Elderly individuals may have increased susceptibility to hematologic toxicity; regular CBC monitoring is especially important in this population. 

- **Can athletes use ticlopidine without violating anti-doping rules?** 
 Ticlopidine is not listed on the World Anti-Doping Agency (WADA) prohibited list, but athletes should disclose its use to their medical team to avoid inadvertent violations related to blood-thinning agents. 

**Scientific & Clinical Curiosity** 

- **Why was ticlopidine replaced by clopidogrel in most guidelines?** 
 Clopidogrel offers comparable antiplatelet efficacy with a markedly lower incidence of severe neutropenia and TTP, leading to its preferential recommendation. 

- **What was the pivotal trial that supported ticlopidine’s approval?** 
 The 1995 European Stroke Prevention Study (ESPS) demonstrated a reduction in recurrent stroke incidence with ticlopidine versus placebo, forming the basis for regulatory approval. 

## Glossary 

**P2Y12 Receptor** 
: A platelet surface protein that binds ADP, triggering platelet activation and aggregation. 

**Thrombotic Thrombocytopenic Purpura (TTP)** 
: A rare, life-threatening condition characterized by clot formation in small blood vessels, rapid platelet depletion, and organ dysfunction. 

**Irreversible Platelet Inhibition** 
: A pharmacologic effect where the drug permanently disables a platelet’s ability to aggregate until new platelets are produced. 

**Good Manufacturing Practices (GMP)** 
: Regulatory standards that ensure pharmaceutical products are consistently produced and controlled according to quality standards. 

**Complete Blood Count (CBC)** 
: A laboratory test measuring the levels of red cells, white cells, and platelets, used to monitor hematologic safety. 

## Disclaimer 

The information provided about **Ticlopidine** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-ticlopidine-online-en.html) offers access to **Ticlopidine** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.